Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AZN

AstraZeneca

$32.68

0.01 (0.03%)

09:53
09/20/17
09/20
09:53
09/20/17
09:53
Conference/Events
AstraZeneca management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

BLUE

bluebird bio

$130.30

-2.75 (-2.07%)

, TSRO

Tesaro

$118.74

0.3 (0.25%)

08:04
09/20/17
09/20
08:04
09/20/17
08:04
Hot Stocks
bluebird bio appoints Mary Lynne Headly to board of directors »

bluebird bio (BLUE)…

BLUE

bluebird bio

$130.30

-2.75 (-2.07%)

TSRO

Tesaro

$118.74

0.3 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 25

    Oct

Monday
CLVS

Clovis

$69.46

-0.57 (-0.81%)

, LLY

Eli Lilly

$82.28

-0.16 (-0.19%)

13:33
09/18/17
09/18
13:33
09/18/17
13:33
Recommendations
Clovis, Eli Lilly analyst commentary at Leerink »

Clovis rumors…

CLVS

Clovis

$69.46

-0.57 (-0.81%)

LLY

Eli Lilly

$82.28

-0.16 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 18

    Oct

CLVS

Clovis

$69.46

-0.57 (-0.81%)

, LLY

Eli Lilly

$82.40

-0.04 (-0.05%)

10:57
09/18/17
09/18
10:57
09/18/17
10:57
Hot Stocks
Clovis not commenting on takeover rumors, focusing on Rubraca »

Contacted by The Fly as…

CLVS

Clovis

$69.46

-0.57 (-0.81%)

LLY

Eli Lilly

$82.40

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 18

    Oct

CLVS

Clovis

$69.46

-0.57 (-0.81%)

, LLY

Eli Lilly

$82.25

-0.195 (-0.24%)

10:32
09/18/17
09/18
10:32
09/18/17
10:32
Hot Stocks
Clovis jumps as takeover rumors resurface »

Shares of Clovis Oncology…

CLVS

Clovis

$69.46

-0.57 (-0.81%)

LLY

Eli Lilly

$82.25

-0.195 (-0.24%)

TSRO

Tesaro

$117.16

1.92 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 27

    Sep

  • 18

    Oct

  • 25

    Oct

CLVS

Clovis

$69.46

-0.57 (-0.81%)

10:09
09/18/17
09/18
10:09
09/18/17
10:09
Rumors
Rumor moving shares of Clovis »

Rumor: Clovis strength…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$32.53

-0.09 (-0.28%)

04:55
09/18/17
09/18
04:55
09/18/17
04:55
Conference/Events
AstraZeneca management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 22

    Sep

Friday
AZN

AstraZeneca

$32.62

-0.03 (-0.09%)

07:50
09/15/17
09/15
07:50
09/15/17
07:50
Conference/Events
AstraZeneca management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 22

    Sep

TSRO

Tesaro

$115.24

-0.39 (-0.34%)

07:47
09/15/17
09/15
07:47
09/15/17
07:47
Hot Stocks
Tesaro receives positive CHMP opinion for Zejula »

Tesaro announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 25

    Oct

Over a week ago
TSRO

Tesaro

$115.24

-0.39 (-0.34%)

16:52
09/14/17
09/14
16:52
09/14/17
16:52
Initiation
Tesaro initiated at RBC Capital »

Tesaro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.